Dodd-Frank Act (2010)

When the Dodd-Frank Wall Street Reform and Consumer Protection Act became law in 2010, it introduced sweeping financial reforms — and its impact went far beyond Wall Street. At Barrett Johnston, we view Dodd-Frank as a landmark in the evolution of whistleblower protections and incentives across all industries, including healthcare.

The Act established the Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) whistleblower programs, offering monetary rewards for tips that lead to successful enforcement actions. More importantly, Dodd-Frank broadened anti-retaliation protections, ensuring that whistleblowers could safely report misconduct both internally and externally.

Some healthcare companies are large enough to be regulated by the SEC (e.g. pharmaceutical companies, for-profit hospital chains), making the Dodd-Frank an important tool for at least some healthcare whistleblowers. And, at a broader level, Dodd-Frank has been an influential model for other whistleblower programs and has reinforced the legitimacy of government payments to whistleblowers and robust confidentiality protections.

For those reporting healthcare fraud, the Dodd-Frank model affirms a principle Barrett Johnston has long supported: transparency thrives when whistleblowers are protected and rewarded.